Jabs DA - Search Results

1

Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome.

Holland GN, Kappel PJ, Van Natta ML, Palella FJ, Lyon AT, Shah KH, Pavan PR, Jabs DA; Studies of the Ocular Complications of AIDS Research Group. Holland GN, et al. Among authors: jabs da. Am J Ophthalmol. 2010 May;149(5):807-16. doi: 10.1016/j.ajo.2009.12.019. Am J Ophthalmol. 2010. PMID: 20399927 Free PMC article.

2

Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

Palay DA, Sternberg P Jr, Davis J, Lewis H, Holland GN, Mieler WF, Jabs DA, Drews C. Palay DA, et al. Among authors: jabs da. Am J Ophthalmol. 1991 Sep 15;112(3):250-5. doi: 10.1016/s0002-9394(14)76725-x. Am J Ophthalmol. 1991. PMID: 1882936

3

Current practices in the management of ocular toxoplasmosis.

Engstrom RE Jr, Holland GN, Nussenblatt RB, Jabs DA. Engstrom RE Jr, et al. Among authors: jabs da. Am J Ophthalmol. 1991 May 15;111(5):601-10. doi: 10.1016/s0002-9394(14)73706-7. Am J Ophthalmol. 1991. PMID: 2021170

4

Ocular manifestations of acquired immune deficiency syndrome.

Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Jabs DA, et al. Ophthalmology. 1989 Jul;96(7):1092-9. doi: 10.1016/s0161-6420(89)32794-1. Ophthalmology. 1989. PMID: 2549483 Free article.

5

Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients.

Elkins BS, Holland GN, Opremcak EM, Dunn JP Jr, Jabs DA, Johnston WH, Green WR. Elkins BS, et al. Among authors: jabs da. Ophthalmology. 1994 Mar;101(3):499-507. doi: 10.1016/s0161-6420(13)31267-6. Ophthalmology. 1994. PMID: 8127570 Free article.

6

Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.

Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Holbrook JT, et al. Among authors: jabs da. Arch Ophthalmol. 2000 Sep;118(9):1196-204. doi: 10.1001/archopht.118.9.1196. Arch Ophthalmol. 2000. PMID: 10980764 Clinical Trial.

7

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Jabs DA, et al. Am J Ophthalmol. 2000 Oct;130(4):492-513. doi: 10.1016/s0002-9394(00)00659-0. Am J Ophthalmol. 2000. PMID: 11024423 Free article. Review.

8

Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients.

Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA; Studies of Ocular Complications of AIDS Research Group. Holbrook JT, et al. Among authors: jabs da. Arch Ophthalmol. 2001 Apr;119(4):554-63. doi: 10.1001/archopht.119.4.554. Arch Ophthalmol. 2001. PMID: 11296021

9

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT. Smith JR, et al. Among authors: jabs da. Arthritis Rheum. 2001 Jun;45(3):252-7. doi: 10.1002/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5. Arthritis Rheum. 2001. PMID: 11409666 Free article.

10

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Jabs DA, et al. Am J Ophthalmol. 2002 Jan;133(1):48-61. doi: 10.1016/s0002-9394(01)01322-8. Am J Ophthalmol. 2002. PMID: 11755839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters